Table 5. The ten-fold cross-validation performance of metal binding sites on Cross-Validation dataset.
ETMB-RBF with different features | True Positive | False Positive | True Negative | False Negative | Sensitivity | Precision | Specificity | Accuracy | MCC |
Metal binding cysteine | |||||||||
AA | 60 | 22 | 90 | 19 | 75.9% | 73.2% | 80.4% | 78.5% | 0.56 |
BLOSUM62 | 65 | 12 | 100 | 14 | 82.3% | 84.4% | 89.3% | 86.4% | 0.72 |
PAM250 | 58 | 9 | 103 | 21 | 73.4% | 86.8% | 92.0% | 84.3% | 0.67 |
PSSM | 76 | 16 | 96 | 3 | 96.2% | 82.6% | 85.7% | 90.1% | 0.81 |
PSSM+SAAPs | 78 | 12 | 100 | 1 | 98.7% | 86.7% | 89.3% | 93.2% | 0.87 |
Metal binding histidine | |||||||||
AA | 37 | 30 | 226 | 40 | 48.1% | 55.2% | 88.3% | 79.0% | 0.38 |
BLOSUM62 | 43 | 21 | 235 | 34 | 55.8% | 67.2% | 91.8% | 83.5% | 0.51 |
PAM250 | 39 | 37 | 219 | 38 | 50.6% | 51.3% | 85.5% | 77.5% | 0.36 |
PSSM | 60 | 13 | 243 | 17 | 77.9% | 82.2% | 94.9% | 91.0% | 0.74 |
PSSM+SAAPs | 62 | 8 | 248 | 15 | 80.5% | 88.6% | 96.9% | 93.1% | 0.80 |